Bolscher J G, van der Bijl M M, Neefjes J J, Hall A, Smets L A, Ploegh H L
Division of Cellular Biochemistry, The Netherlands Cancer Institute, Amsterdam.
EMBO J. 1988 Nov;7(11):3361-8. doi: 10.1002/j.1460-2075.1988.tb03208.x.
The effect of expression of the ras oncogene on protein glycosylation was studied. VSV G-protein and class I histocompatibility antigens were analysed to monitor ras-mediated changes in glycosylation. Transient expression of the c-Ha-ras oncogene, introduced into NIH 3T3 cells by the DEAE-dextran method, altered protein glycosylation within 25 h of transfection. The same result was obtained after dexamethasone-induced expression of p21-ras in stable NIH 3T3 transfectants containing either an activated Ha-ras oncogene or a normal N-ras proto-oncogene under control of the glucocorticoid-inducible MMTV promoter. The alteration of cell surface carbohydrates, induced by the ras (proto)oncogene and the subsequent acquisition of invasive potential, occurred prior to morphological transformation.
研究了ras癌基因表达对蛋白质糖基化的影响。分析了水泡性口炎病毒G蛋白和I类组织相容性抗原,以监测ras介导的糖基化变化。通过DEAE-葡聚糖法将c-Ha-ras癌基因导入NIH 3T3细胞,其瞬时表达在转染后25小时内改变了蛋白质糖基化。在含有活化的Ha-ras癌基因或正常的N-ras原癌基因且受糖皮质激素诱导的MMTV启动子控制的稳定NIH 3T3转染子中,经地塞米松诱导p21-ras表达后也得到了相同的结果。ras(原)癌基因诱导的细胞表面碳水化合物改变以及随后侵袭潜能的获得发生在形态转化之前。